Cultural Adaptation of Drug Treatment for DJJ Youth

NCT ID: NCT06003725

Last Updated: 2025-12-30

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 55 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-05-15
• Study Completion Date: 2027-08-30

Brief Summary

This project aims to improve the understanding of the impact of Ethnic and Racial Discrimination (ERD) on adolescent alcohol and other drug use (AOD) within the Black Justice-Involved Youth (JIY) population. Individual interviews with Black JIY and focus groups with parents and guardians of Black JIY and community members who support change and reform in the justice community for Black JIY will be conducted.

Detailed Description

Black JIY are overrepresented in the criminal justice system due to institutional racism and discrimination. The General Strain Theory posits that high levels of ethnic and racial discrimination (ERD), paired with elevated levels of witnessing or experiencing police brutality, places Black JIY at unique risk of increased alcohol and other drug use (AOD) as a means of coping with stressful events. Black JIY report engaging in comorbid alcohol and cannabis use to achieve temporary respite from discrimination-induced stress. While JIY engage in higher rates of comorbid alcohol and cannabis use compared to non-justice-involved youth, overall, Black JIY are less likely to be diverted to substance use treatment programs, less likely to engage in care after being released on probation, less likely to benefit from substance use treatment in terms of reduced risk of recidivism, and are more adversely affected by early onset of AOD activity than White JIY. To date, no known adolescent substance use treatment directly addresses ERD, the increased risk of AOD due to ERD, or explicitly presents tools on how to appropriately respond to AOD and discrimination distress among Black JIY. To address this problem, the investigator's research program aspires to improve the understanding of the impact of ERD on adolescent AOD within the Black JIY population. Individual interviews with Black JIY and focus groups with guardians of Black JIY and community members will be conducted. Data will be used to culturally adapt an adolescent substance use intervention. The culturally adapted intervention will then be piloted with 30 Black JIY.

Conditions

Substance Use

Keywords

Substance use; substance misuse; adolescent; cultural adaptation

Study Design

• Allocation Method: NA
• Intervention Model: SEQUENTIAL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

ADAP-ITT Phase 8

Phase 8 consists of piloting the culturally adapted CYT intervention with 30 Black JIY to examine feasibility and acceptability.

Group Type: EXPERIMENTAL

Culturally Adapted Adolescent Substance Use Treatment

Intervention Type: BEHAVIORAL

The Cannabis Youth Treatment Series (CYT) (MET/CBT12 model) aims to reduce alcohol and cannabis use.

Interventions

Culturally Adapted Adolescent Substance Use Treatment

The Cannabis Youth Treatment Series (CYT) (MET/CBT12 model) aims to reduce alcohol and cannabis use.

Intervention Type: BEHAVIORAL

Other Intervention Names

Cannabis Youth Treatment Series

Eligibility Criteria

Inclusion Criteria

• 1) Between the ages of 13-17; 2) identify as Black or African American; and 3) on community probation.

• A guardian of JIY
• An advocate (someone who supports change and reform in the justice community) for Black JIY.

• Between the ages of 13 and 17
• Identify as Black or African American
• Be on community probation
• Meet criteria for alcohol, cannabis, or other drug misuse as defined by the DSM 5
• Be experiencing at least 1 problem related to AOD;
• The frequency of AOD must be weekly use over a 3-month period

Exclusion Criteria

• Will be excluded if they do not have parental consent to participate.

For Focus Groups and Interviews:

Adult Participants

• Will be excluded if they do not provide consent to participate.

For pilot feasibility study:

Black JIY Participants:

• Will be excluded if they do not have parental consent to participate
• Parole violation

• Minimum Eligible Age: 13 Years
• Maximum Eligible Age: 17 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

National Institute on Drug Abuse (NIDA)

NIH

Sponsor Role: collaborator

University of California, San Francisco

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Brittany Bryant, DSW

Role: PRINCIPAL_INVESTIGATOR

University of California, San Francisco

Locations

University of California, San Francisco

San Francisco, California, United States

Site Status: RECRUITING

Medical University of South Carolina

Charleston, South Carolina, United States

Site Status: COMPLETED

Countries

United States

Central Contacts

Brittany E Bryant, DSW

Role: CONTACT

Phone: 843-973-0867

Email: brittany.bryant@ucsf.edu

Facility Contacts

Brittany Bryant, DSW

Role: primary

Other Identifiers

K23DA057412

Identifier Type: NIH

Identifier Source: secondary_id

View Link

23-40126

Identifier Type: -

Identifier Source: org_study_id